 SAN DIEGO and REDWOOD CITY, Calif., Feb. 09, 2022 GLOBE NEWSWIRE -- eFFECTOR Therapeutics NASDAQ: EFTR, a biopharmaceutical company focused on pioneering the development of selective translation regulator inhibitors STRIs for the treatment of cancer, today announced that the Company will present and host 1x1 meetings at the 2022 BIO CEO Investor Conference. 